LS

Lihe Su

BM Biogen Idec Ma: 3 patents #75 of 270Top 30%
BG Biogen International Neuroscience Gmbh: 3 patents #8 of 19Top 45%
UZ Universität Zürich: 3 patents #26 of 243Top 15%
BM Biogen Ma: 2 patents #138 of 400Top 35%
US Ucb Biopharma Srl: 2 patents #145 of 349Top 45%
US Ucb Pharma S.A.: 1 patents #143 of 241Top 60%
Overall (All Time): #637,749 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
10301381 Anti-alpha synuclein binding molecules Andreas Weihofen, Jan Grimm, Christoph Hock, Roger Nitsch, Paul H. Weinreb 2019-05-28
9975947 Anti-alpha synuclein binding molecules Andreas Weihofen, Jan Grimm, Christoph Hock, Roger Nitsch, Paul H. Weinreb 2018-05-22
9580493 Anti-α synuclein binding molecules Andreas Weihofen, Jan Grimm, Christoph Hock, Roger Nitsch, Paul H. Weinreb 2017-02-28
9321840 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof Linda C. Burkly, Janine L. Ferrant-Orgettas, Ellen Garber, Yen-Ming Hsu, Frederick R. Taylor +6 more 2016-04-26
9297810 CD40L-binding agent based platelet aggregation assays Yen-Ming Hsu 2016-03-29
8784823 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof Linda C. Burkly, Janine L. Ferrant-Orgettas, Ellen Garber, Yen-Ming Hsu, Frederick R. Taylor +6 more 2014-07-22
8409810 Platelet aggregation assays using a CD40L-binding agent Yen-Ming Hsu 2013-04-02
8293237 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof Linda C. Burkly, Janine L. Ferrant-Orgettas, Ellen Garber, Yen-Ming Hsu, Frederick R. Taylor +6 more 2012-10-23